drugset / Trial / NCT05532527
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of microwave ablation combined with Camrelizumab and chemotherapy in the treatment of patients with advanced non-small cell lung cancer.
Timeline
- Start
- 2022-09-20
- Primary completion
- 2023-09-20
- Completion
- 2025-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Camrelizumab | Monoclonal antibody | — | — |